ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma

NCT02757326 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class

Stopped Expiration of National Cancer Institute (NCI) funding of the study.

Conditions

Interventions

Sponsor

RedHill Biopharma Limited

Collaborators